Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.41 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.41 |
| ▸ | FPR2 | P25090 | 1/20 | 0.41 |
| ▸ | CPA3 | P15088 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1401243 | 0.81 | FFAR1 (0.42) | FFAR1FOLH1MMEHTTTBXA2R | |
| Hydrochloric Acid SCHEMBL1401248 | 0.81 | FFAR1 (0.42) | FFAR1FOLH1MMEHTTTBXA2R | |
| SCHEMBL12226221 | 0.81 | NPSR1 (0.42) | — | |
| SCHEMBL15576913 | 0.79 | FOLH1 (0.39) | FFAR1FOLH1MMETBXA2RPTGER4 | |
| SCHEMBL288670 | 0.74 | FFAR1 (0.50) | FFAR1FOLH1MMEHTTCPA3 | |
| SCHEMBL3251742 | 0.74 | FFAR1 (0.50) | FFAR1FOLH1MMEHTTCPA3 | |
| SCHEMBL12226226 | 0.71 | TRPA1 (0.46) | FFAR1MMETBXA2RPTGER4PTGER3 | |
| SCHEMBL11936645 | 0.71 | FOLH1 (0.78) | FOLH1NAALAD2 | |
| SCHEMBL4138612 | 0.71 | FOLH1 (0.78) | FOLH1NAALAD2 | |
| SCHEMBL193318 | 0.70 | FFAR1 (0.79) | FFAR1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010039531-A1 | THERAPEUTIC COMPOUNDS | RESOLVYX PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |